ReviewExpert review of anticancer therapy2017
Cabozantinib for the treatment of kidney cancer.
Ahmed Abdelaziz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ReviewExpert review of anticancer therapy2017
Ahmed Abdelaziz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.